Canadian Medical Marijuana Executive Addresses Prestigious Global Conference | Financialcontent Business Page

Among the participants are investors with more than $18 trillion in assets under management. Michael Kraft, Chairman of WeedMD , said, “I congratulate the Milken Institute for raising attention for the marijuana industry and including this topic on their agenda for the first time. It was a great opportunity to be chosen as the only Canadian to join the panel and to discuss the evolution and changes in this billion-dollar industry at this important time in its history.” Kraft said, “Canada is leading the way in medical marijuana legislation which is increasing access to higher quality cannabis products and regulating safe production at licensed facilities, and is well-positioned to become a global leader in this multi-billion dollar industry.” Kraft discussed the unique opportunity for American and international investors to invest in Canada’s medical marijuana industry which, according to Health Canada, is expected to reach more than 450,000 users in the next ten years. Kraft presented the distinct advantages available in in the medical marijuana industry in Canada, and the strength and appeal of an investment in Canada, where the market is expected to be worth more than $1-billion annually by 2024. Kraft was the only Canadian on this panel and was joined by leading executives, and experts in the cannabis industry. The panel was moderated by Mike ‘Zappy’ Zapolin of Zappy Inc. and the other panelists included DigiPath CEO, Todd Denkin, National Families in Action Inc.
For the original version including any supplementary images or video, visit http://markets.financialcontent.com/stocks/news/read/27101355/Canadian_Medical_Marijuana_Executive_Addresses_Prestigious_Global_Conference_

Be the first to comment

Leave a Reply

Your email address will not be published.


*